Indo Amines Ltd (INDOAMIN) — shareholding pattern, promoter holding, financials and share price
About Indo Amines Ltd (INDOAMIN)
Indo Amines Ltd operates in the Specialty Chemicals industry, within the Chemicals sector. It trades on the NSE as INDOAMIN and on the BSE under scrip code 524648. Its ISIN is INE760F01028.
Incorporated in 1992, Indo Amines Limited is a global manufacturer and supplier of Fine & Specialty chemicals. [1]
Indo Amines Limited (IAL) is a manufacturer and distributor of specialty chemicals serving various sectors including agrochemicals, pharmaceuticals, and rubber chemicals. The company leverages a strong legacy from its promoters with rich experience in oleochemicals and chemical marketing since the early 1980s.
IAL has shown a strategic focus on expansion as evident from its installation of new Quaternary Ammonium Compounds capacity at Savli, demonstrating commitment to diversify and scale its product offerings.
Listed peers in Specialty Chemicals: Sunshield Chemicals Ltd, Sudarshan Pharma Industries Ltd, Shri Ahimsa Naturals Ltd, Fairchem Organics Ltd, Amal Ltd, Valiant Organics Ltd.
Valuation & Returns
10 Jul 2026At ₹126.15 a share on 10 Jul 2026, Indo Amines Ltd (INDOAMIN) was valued at a price-to-earnings ratio of 11.54x against an industry P/E of 45.11x and a price-to-book of 2.89x on a book value of ₹43.67 per share as of Mar 2025. Solomo computes return on equity of 25.03% and return on capital employed of 21.59% from filed results. Earnings ratios use consolidated results for the twelve months Jun 2025 to Mar 2026.
- P/E
- 11.54x
- Industry P/E
- 45.11x
- P/B
- 2.89x
- EPS (TTM)
- ₹10.93
- Book value / share
- ₹43.67
- ROE
- 25.03%
- ROCE
- 21.59%
- ROA
- 10.19%
- Debt / equity
- 0.9x
- Dividend yield
- 0.39%
- EBITDA margin
- 12.21%
- 52-week range
- ₹82 – ₹167.95
Ratios are computed from filed results and the last recorded price. Not investment advice.
Financial Performance
Mar 2026In the year ended Mar 2026, Indo Amines Ltd (INDOAMIN) reported revenue of ₹1,160 crore, net profit of ₹79 crore and earnings per share of ₹10.93. That compares with revenue of ₹1,079 crore and net profit of ₹56 crore in Mar 2025. Figures are consolidated, as filed with the exchanges.
In the quarter ended Mar 2026, revenue was ₹318 crore and net profit ₹21 crore (consolidated).
| Metric | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Revenue (₹ cr) | 786 | 945 | 943 | 1,079 | 1,160 |
| Net profit (₹ cr) | 23 | 41 | 43 | 56 | 79 |
| EPS (₹) | 3.23 | 5.72 | 6.05 | 7.61 | 10.93 |
| Measure | 10Y | 5Y | 3Y | 1Y |
|---|---|---|---|---|
| Sales growth | 17.17% | 17.47% | 10.64% | 14.33% |
| Profit growth | 24.43% | 34.80% | 35.08% | 30.09% |
| Stock price CAGR | 18% | 1% | 4% | -22% |
Ownership Summary
Jun 2026As of Jun 2026, promoters hold 58.42% of Indo Amines Ltd (INDOAMIN) (unchanged from the previous quarter), foreign institutional investors (FII) hold 0.08% and domestic institutional investors (DII) hold 0%. Market capitalisation was ₹916 crore on 10 Jul 2026. Shareholding is filed quarterly with BSE and NSE; Solomo carries every filing back to Mar 2001.
Largest disclosed public shareholders in Jun 2026: UNIGROUP RESOURCES LLP 8.43%, INVESTOR EDUCATION AND PROTECTION FUND AUTHORITY MINISTRY OF CORPORATE AFFAIRS 3.95%, SANGEETHA S 3.44%, NANDU HARIPRASAD GUPTA 1.66%, PRAMILA NANDU GUPTA 1.48%, SANTOSH KUMAR KHEMKA 1.01%. Only stakes above the 1% disclosure threshold are named in filings.
| Quarter | Promoter | Pledged | FII | DII | Public |
|---|---|---|---|---|---|
| Jun 2026 | 58.42% | - | 0.08% | 0% | 41.58% |
| Mar 2026 | 58.42% | - | 0.02% | - | 41.58% |
| Dec 2025 | 58.42% | - | 0% | - | 41.58% |
| Sep 2025 | 58.42% | - | 0% | - | 41.58% |
| Jun 2025 | 58.42% | - | 0.03% | - | 41.58% |
| Mar 2025 | 58.37% | - | 0.11% | - | 41.63% |
| Dec 2024 | 57.25% | - | 0.16% | - | 42.75% |
| Sep 2024 | 57.25% | - | 0.01% | - | 42.75% |